Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Imugene ( (AU:IMU) ) has issued an announcement.
Imugene Limited has reported the cessation of several classes of equity incentives listed on the ASX, including multiple series of options and restricted stock units that have lapsed or expired unexercised as of 5 January 2026. The announcement details that these securities ceased because the performance or vesting conditions were not met or became incapable of being satisfied, resulting in the expiry of a total of more than one million potential securities and effectively reducing the company’s pool of outstanding equity-based instruments, which may have implications for future dilution and the structure of employee and executive incentive arrangements.
The most recent analyst rating on (AU:IMU) stock is a Hold with a A$0.36 price target. To see the full list of analyst forecasts on Imugene stock, see the AU:IMU Stock Forecast page.
More about Imugene
YTD Price Performance: -5.48%
Average Trading Volume: 1,442,312
Technical Sentiment Signal: Sell
Current Market Cap: A$109.7M
Find detailed analytics on IMU stock on TipRanks’ Stock Analysis page.